We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
(-3%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$101M |
| 2 |
Amazon
AMZN
|
+$99.5M |
| 3 |
Microsoft
MSFT
|
+$95.8M |
| 4 |
Linde
LIN
|
+$84.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$77.4M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$35.2M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$14.7M |
| 4 |
CA
CA, Inc.
CA
|
+$13.2M |
| 5 |
Clorox
CLX
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 13.08% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Consumer Staples | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
PVH
PVH
$3.71B
| $861K | 0.01% |
9,264
+1,006
| +12% | +$115K |
|
752
Leidos
LDOS
$14.1B
| $859K | 0.01% |
16,300
-5,555
| -25% | -$345K |
|
|
XLRN
753
DELISTED
Acceleron Pharma
XLRN
| $859K | 0.01% |
19,734
-3,761
| -16% | -$188K |
|
|
MDSO
754
DELISTED
Medidata Solutions, Inc.
MDSO
| $857K | 0.01% |
12,705
-2,997
| -19% | -$212K |
|
755
Silicon Laboratories
SLAB
$7.15B
| $856K | 0.01% |
10,861
-2,359
| -18% | -$196K |
|
|
ARNA
756
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $855K | 0.01% |
21,961
-4,238
| -16% | -$166K |
|
|
WRI
757
DELISTED
Weingarten Realty Investors
WRI
| $848K | 0.01% |
34,167
-3,229
| -9% | -$89.7K |
|
758
Ascendis Pharma A/S
ASND
$16.7B
| $843K | 0.01% |
13,448
-2,656
| -16% | -$167K |
|
|
MYOK
759
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $842K | 0.01% |
17,237
-3,285
| -16% | -$181K |
|
760
Howard Hughes
HHH
$3.93B
| $840K | 0.01% |
9,022
-476
| -5% | -$49.5K |
|
761
Whirlpool
WHR
$2.42B
| $836K | 0.01% |
7,824
-2,549
| -25% | -$289K |
|
|
PCH
762
DELISTED
PotlatchDeltic
PCH
| $832K | 0.01% |
26,309
-861
| -3% | -$30.7K |
|
763
CoreCivic
CXW
$3.1B
| $830K | 0.01% |
46,561
-5,305
| -10% | -$116K |
|
|
ULTI
764
DELISTED
Ultimate Software Group Inc
ULTI
| $830K | 0.01% |
3,390
-1,125
| -25% | -$298K |
|
765
Teradyne
TER
$54.8B
| $827K | 0.01% |
26,351
-7,934
| -23% | -$269K |
|
|
IBKC
766
DELISTED
IBERIABANK Corp
IBKC
| $821K | 0.01% |
12,766
-1,322
| -9% | -$97.1K |
|
767
FirstCash
FCFS
$8.55B
| $815K | 0.01% |
11,264
-932
| -8% | -$74.3K |
|
768
Cheniere Energy
LNG
$56.5B
| $815K | 0.01% |
13,765
+3,354
| +32% | +$206K |
|
769
First Horizon
FHN
$12.1B
| $813K | 0.01% |
61,801
-7,322
| -11% | -$114K |
|
|
ENDP
770
DELISTED
Endo International plc
ENDP
| $813K | 0.01% |
111,380
-19,702
| -15% | -$270K |
|
771
Supernus Pharmaceuticals
SUPN
$2.68B
| $808K | 0.01% |
24,337
-4,265
| -15% | -$183K |
|
772
Radian Group
RDN
$5.14B
| $807K | 0.01% |
49,320
-4,894
| -9% | -$89.3K |
|
|
FOLD
773
DELISTED
Amicus Therapeutics
FOLD
| $805K | 0.01% |
84,059
-16,230
| -16% | -$178K |
|
774
Fulton Financial
FULT
$4.7B
| $802K | 0.01% |
51,809
-6,739
| -12% | -$110K |
|
|
EQC
775
DELISTED
Equity Commonwealth
EQC
| $802K | 0.01% |
26,715
-1,387
| -5% | -$42.3K |
|
Similar funds
ProShare Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.
- ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
- ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
- ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
- ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
- ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
- ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
- ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.
Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.